Results 261 to 270 of about 1,998,403 (289)
Some of the next articles are maybe not open access.

Radiotherapy, immunity, and immune checkpoint inhibitors

The Lancet Oncology
Radiotherapy exerts immunostimulatory and immunosuppressive effects, both locally, within the irradiated tumour microenvironment, and systemically, outside the radiation field. Inspired by preclinical data that showed synergy between radiotherapy and immune checkpoint inhibitors, multiple clinical trials were initiated with the hypothesis that combined
Connor, Lynch   +2 more
openaire   +2 more sources

Immune checkpoint inhibitor myocarditis

Current Opinion in Cardiology, 2019
The purpose of this study is to summarize and highlight the recent literature regarding immune checkpoint inhibitor myocarditis.The use of immune checkpoint inhibitors, a promising form of immunotherapy, is rapidly increasing in oncology. These drugs have been recently found to cause a fulminant myocarditis associated with a high-case fatality rate ...
Jayant, Raikhelkar, Nir, Uriel
openaire   +2 more sources

The Broadening Scope of Oral Mucositis and Oral Ulcerative Mucosal Toxicities of Anticancer Therapies

Ca-A Cancer Journal for Clinicians, 2022
Stephen Sonis   +2 more
exaly  

Biomarkers for immune checkpoint inhibitors

The Lancet Oncology, 2014
Lysanne A, Lievense   +2 more
openaire   +2 more sources

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

A Review of Cancer Immunotherapy Toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

An Update on the Immune Landscape in Lung and Head and Neck Cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle   +2 more
exaly  

Home - About - Disclaimer - Privacy